Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing
- 8 November 2023
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 40 (12) , 1-8
Abstract
Background Disease prognosis after resection of lung cancer could be affected by pathological subtypes. In this study, we investigated the difference of gene variation and significantly altered pathways between adenocarcinoma in situ (AIS)/microinvasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC) subtypes to reveal the molecular mechanism of prognosis differences. Methods Sixty one tumor tissues were subjected to DNA extraction and customized 136 gene targeted next-generation sequencing. Comparisons between groups were performed with two-sided Fisher’s exact test for categorical variables and two-tailed unpaired t test for numerical variables. Results A total of 402 somatic mutations involved in 70 genes were detected in all these samples, and 74.29% of these genes were mutated in at least two samples. PMS2, ARID1A, EGFR, and POLE were the most frequently mutated genes. ALK_EML4 fusion was observed in one IAC patient and RET_ KIF5B fusion in one AIS patient. A significant higher proportion of patients with TP53 gene mutation was observed in the IAC group (P = 0.0057). The average onset age in IAC group is 62.48 years, which is greater than other subtypes (P = 0.0166). It revealed that mutations in genes involved in the mTOR signaling pathway (56.52% vs 26.32%, P = 0.0288) and Hippo signaling pathway (34.78% vs 10.53%, P = 0.0427) were significantly enriched in IAC subtypes, suggesting the key involvement of mTOR and Hippo signaling pathways in lung tumor development and malignant progression. Conclusions This study revealed the heterogeneity of gene mutations and significantly altered pathways between different lung cancer subtypes, suggesting the potential mechanism of different prognosis.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (2042022kf1094)
This publication has 46 references indexed in Scilit:
- Predictive Value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Tumor Recurrence and Patient SurvivalJournal of Clinical Oncology, 2014
- A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin SensitivityCancer Discovery, 2014
- Tumor‐propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasisThe EMBO Journal, 2014
- Why Do Pathological Stage IA Lung Adenocarcinomas Vary from Prognosis?: A Clinicopathologic Study of 176 Patients with Pathological Stage IA Lung Adenocarcinoma Based on the IASLC/ATS/ERS ClassificationJournal of Thoracic Oncology, 2013
- The translational landscape of mTOR signalling steers cancer initiation and metastasisNature, 2012
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung AdenocarcinomaJournal of Thoracic Oncology, 2011
- Clinical Relevance of Microsatellite Instability in Colorectal CancerJournal of Clinical Oncology, 2010
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- The coordinate regulation of the p53 and mTOR pathways in cellsProceedings of the National Academy of Sciences, 2005
- SIFT: predicting amino acid changes that affect protein functionNucleic Acids Research, 2003